NEWS UPDATE
BERITA TERBARU
Peluncuran Tablet Multiple Micronutrient Supplement (MMS) untuk Penuhi Gizi Ibu Hamil dan Cegah Stunting
Pada tanggal 17 Oktober 2024, Kementerian Kesehatan Republik Indonesia meluncurkan tablet Multiple Micronutrient Supplement (MMS) di Kota Bandung, Jawa Barat, sebagai pengganti Tablet Tambah Darah (TTD) untuk penuhi gizi bagi ibu hamil.
Pada sambutannya, Menteri Budi Gunadi Sadikin menyatakan bahwa, berdasarkan hasil penelitian, penggunaan MMS memberikan dampak positif yang signifikan bagi kesehatan ibu dan bayi. Ibu hamil yang mengonsumsi MMS cenderung memiliki status gizi yang lebih baik, dan bayi yang dilahirkan lebih sehat. Suplemen ini diyakini memiliki manfaat lebih besar karena mengandung 10 vitamin dan lima mineral yang menjadikannya total 15 nutrisi penting bagi perkembangan ibu hamil. Jika dibandingkan dengan TTD yang hanya mengandung satu vitamin dan satu mineral, MMS jauh lebih lengkap. Penyakit yang menyerang ibu hamil dan anak-anak adalah penyakit gizi, yang berarti asupan gizinya sangat kurang. Dari 4,9 juta ibu hamil, 27 persen mengalami anemia, dan itu angka yang sangat tinggi.
Menkes Budi menyebutkan bahwa permasalahan kurang gizi pada ibu hamil di Indonesia menjadi perhatian pihaknya dan berbagai ahli gizi dunia. Oleh karena itu, Kemenkes bersama lembaga kesehatan dunia dan lembaga kesejahteraan anak seperti WHO dan UNICEF merekomendasikan penggunaan MMS untuk memenuhi kebutuhan nutrisi ibu hamil. Ini sudah menjadi panduan dari WHO sejak 2020, dan kita baru mulai menerapkannya sekarang.
Dalam acara yang sama, Direktur Jenderal Kesehatan Masyarakat Kemenkes Maria Endang Sumiwi menjelaskan bahwa setiap tablet MMS mengandung 10 vitamin dan 5 mineral. Nutrisi penting bagi ibu hamil yang terkandung dalam MMS antara lain vitamin A, D, E, C, B1, B2, niasin, B6, B12, asam folat, zat besi, zinc, tembaga, selenium, dan iodin.
Kemenkes menargetkan implementasi pemberian MMS pada ibu hamil secara nasional tahun depan, dengan prioritas pada 15 provinsi yang memiliki kasus kelahiran bayi dengan berat badan lahir rendah (BBLR) tertinggi. Dimulai di Jawa Barat, karena provinsi ini yang paling banyak ibu hamilnya. Setiap ibu hamil di Indonesia diperkirakan memerlukan 180 tablet MMS selama enam bulan. Kemenkes memperkirakan sekitar 900 juta tablet diperlukan setiap tahunnya untuk memenuhi kebutuhan ibu hamil di seluruh Indonesia. Untuk kebutuhan tahun 2024, sebanyak 1,3 juta botol MMS, masing-masing berisi 180 tablet, telah disiapkan untuk didistribusikan kepada ibu hamil, dan sosialisasi program telah dilakukan di berbagai kabupaten dan kota terpilih.
Untuk mendukung keberlanjutan program MMS, diterbitkan Keputusan Menteri Kesehatan Nomor: HK.01.0/MENKES/1092/2024 tentang Standar Suplemen Zat Gizi Mikro untuk Ibu Hamil. Selain itu, dukungan dari Badan POM dengan penerbitan Peraturan Kepala BPOM Nomor: 15 Tahun 2024 tentang Perubahan atas Peraturan Badan Pengawas Obat dan Makanan Nomor 32 Tahun 2022 mengenai Kriteria dan Tata Laksana Registrasi Suplemen Kesehatan, yang merevisi batas maksimum untuk Selenium pada ibu hamil, sehingga tablet MMS bisa didaftarkan sebagai Suplemen Kesehatan. Program MMS juga telah didukung oleh penelitian yang dilakukan oleh berbagai universitas, seperti Universitas Indonesia, Universitas Airlangga, dan Universitas Hasanuddin.
Hingga saat ini tablet MMS masih diproduksi dari luar negeri dengan bantuan dari berbagai organisasi kesehatan dunia seperti Vitamin Angel, Kirk Humanitarian, dan UNICEF. Dua hingga tiga tahun ke depan, pemerintah mengharapkan produksi suplemen MMS dapat dilakukan di dalam negeri sehingga mampu memenuhi kebutuhan nasional dan diharapkan Indonesia bisa menjadi pemasok MMS bagi negara-negara lain di masa depan. Untuk itu, telah dilaksanakan coaching clinic guna memperkuat kapasitas industri lokal dalam menyiapkan produk untuk kepentingan program pemerintah, komersial, dan ekspor pada 8-9 Oktober 2024.
Disusun oleh: Santi Rahmayanti
Sumber: Antara, Kemenkes RI.
Launch of Multiple Micronutrient Supplement (MMS) Tablets to Meet Nutritional Needs of Pregnant Women and Prevent Stunting
On October 17, 2024, the Ministry of Health of the Republic of Indonesia launched the Multiple Micronutrient Supplement (MMS) tablets in Bandung City, West Java, as a replacement for Iron-Folic Acid Tablets (TTD) to meet nutrition needs for pregnant women.
In his remarks, Minister Budi Gunadi Sadikin stated that, based on research findings, the use of MMS provides a significant positive impact on the health of mothers and babies{rm}. Pregnant women who consume MMS tend to have better nutritional status, and babies born are healthier. This supplement is believed to offer greater benefits because it contains 10 vitamins and five minerals, making a total of 15 essential nutrients for maternal development. When compared to TTD, which contains only one vitamin and one mineral, MMS is far more complete. Diseases affecting pregnant women and children are nutritional diseases, which means their nutrient intake is critically lacking. Out of 4.9 million pregnant women, 27 percent experience anemia, and that is a very high number.
Minister Budi mentioned that the issue of malnutrition among pregnant women in Indonesia has become a concern for his ministry and various global nutrition experts. Therefore, the Ministry of Health together with global health and child welfare organizations such as WHO and UNICEF recommend the use of MMS to meet the nutritional needs of pregnant women. This has been a WHO guideline since 2020, and we are only now beginning to implement it.
In the same event, the Director General of Public Health at the Ministry of Health, Maria Endang Sumiwi, explained that each MMS tablet contains 10 vitamins and 5 minerals. Essential nutrients for pregnant women contained in MMS include vitamins A, D, E, C, B1, B2, niacin, B6, B12, folic acid, iron, zinc, copper, selenium, and iodine.
The Ministry of Health targets national implementation of MMS supplementation for pregnant women next year, prioritizing 15 provinces with the highest cases of low birth weight (LBW). It begins in West Java, because this province has the highest number of pregnant women. Each pregnant woman in Indonesia is expected to require 180 MMS tablets over six months. The Ministry estimates that around 900 million tablets will be needed annually to meet the needs of pregnant women across Indonesia. For 2024, a total of 1.3 million bottles of MMS, each containing 180 tablets, have been prepared for distribution to pregnant women, and program socialization has been carried out in selected districts and cities.
To support the sustainability of the MMS program, the Minister of Health Decree Number: HK.01.0/MENKES/1092/2024 concerning Standards for Micronutrient Supplements for Pregnant Women has been issued. In addition, support from the Food and Drug Authority (BPOM) was provided through the issuance of BPOM Regulation Number: 15 of 2024 concerning Amendments to BPOM Regulation Number 32 of 2022 regarding Criteria and Procedures for Health Supplement Registration, which revises the maximum limit for Selenium for pregnant women, allowing MMS tablets to be registered as Health Supplements. The MMS program has also been supported by research conducted by several universities, such as Universitas Indonesia, Universitas Airlangga, and Universitas Hasanuddin.
Until now, MMS tablets are still produced abroad with assistance from various global health organizations such as Vitamin Angel, Kirk Humanitarian, and UNICEF. In the next two to three years, the government expects MMS supplement production to be carried out domestically so that it can meet national needs, and it is hoped that Indonesia will be able to become an MMS supplier for other countries in the future. To support this, a coaching clinic was conducted to strengthen the capacity of local industry in preparing products for government programs, commercial needs, and exports on October 8–9, 2024.
Prepared by:* Santi Rahmayanti
Antara, Ministry of Health of the Republic of Indonesia.
On October 17, 2024, the Ministry of Health of the Republic of Indonesia launched the Multiple Micronutrient Supplement (MMS) tablets in Bandung City, West Java, as a replacement for Iron-Folic Acid Tablets (TTD) to meet nutrition needs for pregnant women.
In his remarks, Minister Budi Gunadi Sadikin stated that, based on research findings, the use of MMS {rm}provides a significant positive impact on the health of mothers and babies. Pregnant women who consume MMS tend to have better nutritional status, and babies born are healthier. This supplement is believed to offer greater benefits because it contains 10 vitamins and five minerals, making a total of 15 essential nutrients for maternal development. When compared to TTD, which contains only one vitamin and one mineral, MMS is far more complete. Diseases affecting pregnant women and children are nutritional diseases, which means their nutrient intake is critically lacking. Out of 4.9 million pregnant women, 27 percent experience anemia, and that is a very high number.
Minister Budi mentioned that the issue of malnutrition among pregnant women in Indonesia has become a concern for his ministry and various global nutrition experts. Therefore, the Ministry of Health together with global health and child welfare organizations such as WHO and UNICEF recommend the use of MMS to meet the nutritional needs of pregnant women. This has been a WHO guideline since 2020, and we are only now beginning to implement it.
In the same event, the Director General of Public Health at the Ministry of Health, Maria Endang Sumiwi, explained that each MMS tablet contains 10 vitamins and 5 minerals. Essential nutrients for pregnant women contained in MMS include vitamins A, D, E, C, B1, B2, niacin, B6, B12, folic acid, iron, zinc, copper, selenium, and iodine.
The Ministry of Health targets national implementation of MMS supplementation for pregnant women next year, prioritizing 15 provinces with the highest cases of low birth weight (LBW). It begins in West Java, because this province has the highest number of pregnant women. Each pregnant woman in Indonesia is expected to require 180 MMS tablets over six months. The Ministry estimates that around 900 million tablets will be needed annually to meet the needs of pregnant women across Indonesia. For 2024, a total of 1.3 million bottles of MMS, each containing 180 tablets, have been prepared for distribution to pregnant women, and program socialization has been carried out in selected districts and cities.
To support the sustainability of the MMS program, the Minister of Health Decree Number: HK.01.0/MENKES/1092/2024 concerning Standards for Micronutrient Supplements for Pregnant Women has been issued. In addition, support from the Food and Drug Authority (BPOM) was provided through the issuance of BPOM Regulation Number: 15 of 2024 concerning Amendments to BPOM Regulation Number 32 of 2022 regarding Criteria and Procedures for Health Supplement Registration, which revises the maximum limit for Selenium for pregnant women, allowing MMS tablets to be registered as Health Supplements. The MMS program has also been supported by research conducted by several universities, such as Universitas Indonesia, Universitas Airlangga, and Universitas Hasanuddin.
Until now, MMS tablets are still produced abroad with assistance from various global health organizations such as Vitamin Angel, Kirk Humanitarian, and UNICEF. In the next two to three years, the government expects MMS supplement production to be carried out domestically so that it can meet national needs, and it is hoped that Indonesia will be able to become an MMS supplier for other countries in the future. To support this, a coaching clinic was conducted to strengthen the capacity of local industry in preparing products for government programs, commercial needs, and exports on October 8–9, 2024.
Prepared by:* Santi Rahmayanti
Antara, Ministry of Health of the Republic of Indonesia.